Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The central nervous system (CNS) is the part of thenervous system consisting of the brain and spinal cord.
The report details the trend, potential and market size of Central Nervous System Therapeutic market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Central Nervous System Therapeuticmarket, defines the market attractiveness level of Central Nervous System Therapeutic market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Central Nervous System Therapeutic industry, describes the types of Central Nervous System Therapeutic market, the applications of major players and the market size, and deeply analyzes the current situation of the global Central Nervous System Therapeutic market and the development prospects and opportunities of Central Nervous System Therapeutic industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Central Nervous System Therapeutic market in Chapter 13.
By Player:
Johnson & Johnson
Merck
Novartis
Novartis
Shire
AstraZeneca
Pfizer
Otsuka
Biogen
Novartis
Teva
By Type:
OTC
Rx Drugs
By End-User:
Hospital
Retail Pharmacy
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Central Nervous System Therapeutic Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Central Nervous System Therapeutic Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Central Nervous System Therapeutic Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Central Nervous System Therapeutic Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Central Nervous System Therapeutic Market Analysis and Outlook to 2022
-
7.1 Global Central Nervous System Therapeutic Consumption (2017-2022)
-
7.2 United States Central Nervous System Therapeutic Consumption (2017-2022)
-
7.3 Europe Central Nervous System Therapeutic Consumption (2017-2022)
-
7.4 China Central Nervous System Therapeutic Consumption (2017-2022)
-
7.5 Japan Central Nervous System Therapeutic Consumption (2017-2022)
-
7.6 India Central Nervous System Therapeutic Consumption (2017-2022)
-
7.7 South Korea Central Nervous System Therapeutic Consumption (2017-2022)
8 Region and Country-wise Central Nervous System Therapeutic Market Analysis and Outlook to 2028
-
8.1 Global Central Nervous System Therapeutic Consumption Forecast (2022-2028)
-
8.2 United States Central Nervous System Therapeutic Consumption Forecast (2022-2028)
-
8.3 Europe Central Nervous System Therapeutic Consumption Forecast (2022-2028)
-
8.4 China Central Nervous System Therapeutic Consumption Forecast (2022-2028)
-
8.5 Japan Central Nervous System Therapeutic Consumption Forecast (2022-2028)
-
8.6 India Central Nervous System Therapeutic Consumption Forecast (2022-2028)
-
8.7 South Korea Central Nervous System Therapeutic Consumption Forecast (2022-2028)
9 Global Central Nervous System Therapeutic Market Outlook by Types and Applications to 2022
-
9.1 Global Central Nervous System Therapeutic Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global OTC Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Rx Drugs Consumption and Growth Rate (2017-2022)
-
9.2 Global Central Nervous System Therapeutic Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacy Consumption and Growth Rate (2017-2022)
10 Global Central Nervous System Therapeutic Market Outlook by Types and Applications to 2028
-
10.1 Global Central Nervous System Therapeutic Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global OTC Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Rx Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Central Nervous System Therapeutic Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)
11 Global Central Nervous System Therapeutic Import and Export Analysis (Top 5 Countries)
-
11.1 Global Central Nervous System Therapeutic Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Central Nervous System Therapeutic Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Central Nervous System Therapeutic Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Central Nervous System Therapeutic Market Competitive Analysis
-
14.1 Johnson & Johnson
-
14.1.1 Johnson & Johnson Company Details
-
14.1.2 Johnson & Johnson Central Nervous System Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Johnson & Johnson Central Nervous System Therapeutic Product and Service
-
14.2 Merck
-
14.2.1 Merck Company Details
-
14.2.2 Merck Central Nervous System Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merck Central Nervous System Therapeutic Product and Service
-
14.3 Novartis
-
14.3.1 Novartis Company Details
-
14.3.2 Novartis Central Nervous System Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis Central Nervous System Therapeutic Product and Service
-
14.4 Novartis
-
14.4.1 Novartis Company Details
-
14.4.2 Novartis Central Nervous System Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novartis Central Nervous System Therapeutic Product and Service
-
14.5 Shire
-
14.5.1 Shire Company Details
-
14.5.2 Shire Central Nervous System Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Shire Central Nervous System Therapeutic Product and Service
-
14.6 AstraZeneca
-
14.6.1 AstraZeneca Company Details
-
14.6.2 AstraZeneca Central Nervous System Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 AstraZeneca Central Nervous System Therapeutic Product and Service
-
14.7 Pfizer
-
14.7.1 Pfizer Company Details
-
14.7.2 Pfizer Central Nervous System Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Pfizer Central Nervous System Therapeutic Product and Service
-
14.8 Otsuka
-
14.8.1 Otsuka Company Details
-
14.8.2 Otsuka Central Nervous System Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Otsuka Central Nervous System Therapeutic Product and Service
-
14.9 Biogen
-
14.9.1 Biogen Company Details
-
14.9.2 Biogen Central Nervous System Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Biogen Central Nervous System Therapeutic Product and Service
-
14.10 Novartis
-
14.10.1 Novartis Company Details
-
14.10.2 Novartis Central Nervous System Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Novartis Central Nervous System Therapeutic Product and Service
-
14.11 Teva
-
14.11.1 Teva Company Details
-
14.11.2 Teva Central Nervous System Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Teva Central Nervous System Therapeutic Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Central Nervous System Therapeutic
-
Figure Central Nervous System Therapeutic Picture
-
Table Global Central Nervous System Therapeutic Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Central Nervous System Therapeutic Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Central Nervous System Therapeutic Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Central Nervous System Therapeutic Consumption by Country (2017-2022)
-
Figure United States Central Nervous System Therapeutic Consumption and Growth Rate (2017-2022)
-
Table Europe Central Nervous System Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure China Central Nervous System Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure Japan Central Nervous System Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure India Central Nervous System Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure South Korea Central Nervous System Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure Global Central Nervous System Therapeutic Consumption Forecast by Country (2022-2028)
-
Figure United States Central Nervous System Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Central Nervous System Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Central Nervous System Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Central Nervous System Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Central Nervous System Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Central Nervous System Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global OTC Consumption and Growth Rate (2017-2022)
-
Figure Global Rx Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global OTC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rx Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Central Nervous System Therapeutic Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Central Nervous System Therapeutic Export by Region (Top 5 Countries) (2017-2028)
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Central Nervous System Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Central Nervous System Therapeutic Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Central Nervous System Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Central Nervous System Therapeutic Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Central Nervous System Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Central Nervous System Therapeutic Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Central Nervous System Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Central Nervous System Therapeutic Product and Service
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Central Nervous System Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Central Nervous System Therapeutic Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Central Nervous System Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Central Nervous System Therapeutic Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Central Nervous System Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Central Nervous System Therapeutic Product and Service
-
Table Otsuka (Foundation Year, Company Profile and etc.)
-
Table Otsuka Central Nervous System Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Otsuka Central Nervous System Therapeutic Product and Service
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Central Nervous System Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Central Nervous System Therapeutic Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Central Nervous System Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Central Nervous System Therapeutic Product and Service
-
Table Teva (Foundation Year, Company Profile and etc.)
-
Table Teva Central Nervous System Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Central Nervous System Therapeutic Product and Service
-
